Quercetin Reduces Blood Pressure in Hypertensive Subjects
Notes for this study:
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 41 |
| Sex | Both Genders |
| Age Range | 45-64 |
| Body Types | Overweight |
Supplementation of 730mg quercetin aglycone (two divided doses) for four weeks in persons with stage I hypertension is sufficient to reduce blood pressure, which did not occur in persons with normal blood pressure. The lipid panel and biomarkers of oxidation were unchanged in both groups.
